Key Points
- Director insider sale: Scott Saunders sold 203 Nutex Health shares for approximately $43,493, reducing his direct holdings by 33.67% to 400 shares.
- Strong earnings performance: Nutex Health reported quarterly EPS of $9.38, beating the $4.95 consensus estimate, while revenue reached $210.75 million.
- Positive analyst outlook: The stock has a consensus “Buy” rating and an average price target of $317.50, despite mixed individual ratings and recent trading volatility.
Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) Director Scott Saunders sold 203 shares of the firm's stock in a transaction that occurred on Friday, September 18th. The stock was sold at an average price of $214.25, for a total value of $43,492.75. Following the completion of the sale, the director directly owned 400 shares in the company, valued at approximately $85,700. This trade represents a 33.67% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Nutex Health Trading Down 2.6%
NASDAQ:NUTX opened at $208.79 on Friday. The firm has a market capitalization of $1.43 billion, a P/E ratio of 8.20 and a beta of 0.28. The business has a 50 day simple moving average of $179.58 and a 200 day simple moving average of $143.77. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96. Nutex Health Inc. has a 12-month low of $83.99 and a 12-month high of $224.28.
Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, topping the consensus estimate of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%.The firm had revenue of $210.75 million for the quarter, compared to analyst estimates of $215.03 million. Equities research analysts predict that Nutex Health Inc. will post 27.58 EPS for the current year.
Analysts Set New Price Targets
A number of research firms have issued reports on NUTX. Weiss Ratings raised shares of Nutex Health from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday, July 28th. Zacks Research raised Nutex Health from a "hold" rating to a "strong-buy" rating in a report on Monday, August 24th. Lake Street Capital reiterated a "buy" rating and set a $310.00 price objective (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. Wall Street Zen lowered Nutex Health from a "buy" rating to a "hold" rating in a report on Saturday, September 5th. Finally, B Riley restated a "buy" rating on shares of Nutex Health in a research report on Friday, September 4th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, Nutex Health currently has a consensus rating of "Buy" and a consensus target price of $317.50.
View Our Latest Stock Report on Nutex Health
Institutional Investors Weigh In On Nutex Health
Several institutional investors have recently bought and sold shares of NUTX. Allworth Financial LP grew its position in Nutex Health by 41.0% in the 2nd quarter. Allworth Financial LP now owns 203 shares of the company's stock valued at $35,000 after buying an additional 59 shares in the last quarter. Kilter Group LLC bought a new stake in shares of Nutex Health during the 2nd quarter worth about $27,000. Islay Capital Management LLC acquired a new stake in shares of Nutex Health in the 4th quarter worth approximately $34,000. Corient Private Wealth LP lifted its stake in shares of Nutex Health by 5.1% in the 2nd quarter. Corient Private Wealth LP now owns 6,684 shares of the company's stock worth $1,142,000 after acquiring an additional 325 shares during the period. Finally, EverSource Wealth Advisors LLC bought a new position in shares of Nutex Health in the first quarter valued at approximately $83,000. Institutional investors and hedge funds own 5.32% of the company's stock.
About Nutex Health
(
Get Free Report)
Nutex Health Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, outpatient facilities and physician practices. The company focuses on delivering emergency, inpatient and outpatient care through community-based healthcare facilities, including micro-hospitals designed to provide essential hospital services in convenient local settings.
Its services may include emergency medicine, primary care, specialty care, diagnostic testing, imaging, laboratory services and other ancillary healthcare offerings.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
